Collateral resistance to oestrogen and erbB receptor activated growth in endocrine resistant breast cancer
A panel of breast cancer cell lines (MIII, LCC1, LCC2, LCC9, LY2) derived from the MCF-7 breast cancer cell line with varying oestrogen and anti-oestrogen insensitivity (termed ‘resistant’) was used as a model to determine signalling pathways which may contribute to the development of this insensiti...
Main Author: | |
---|---|
Published: |
University of Edinburgh
2007
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.657963 |